{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:51:25Z","timestamp":1790819485954,"version":"4.1.0"},"reference-count":20,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,9,25]]},"DOI":"10.1253\/circj.cj-19-0412","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T22:04:01Z","timestamp":1566252241000},"page":"2025-2033","source":"Crossref","is-referenced-by-count":82,"title":["Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome\u3000\u2015 The ODYSSEY J-IVUS Trial \u2015"],"prefix":"10.1253","volume":"83","author":[{"given":"Junya","family":"Ako","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Hibi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Hiro","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Morino","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kozuma","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Teikyo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Shinke","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Showa University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Otake","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Uno","sequence":"additional","affiliation":[{"name":"Cardiovascular Medical, Sanofi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Louie","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Takagi","sequence":"additional","affiliation":[{"name":"Clinical Sciences and Operations, Sanofi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pilgrim T, Vranckx P, Valgimigli M, Stefanini GG, Piccolo R, Rat J, et al. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction. <i>Am Heart J<\/i> 2016; 175: 56\u201365.","DOI":"10.1016\/j.ahj.2016.01.021"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: Nationwide real world data demonstrate the importance of a long-term perspective. <i>Eur Heart J<\/i> 2015; 36: 1163\u20131170.","DOI":"10.1093\/eurheartj\/ehu505"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. 2012 ACCF\/AHA focused update incorporated into the ACCF\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2013; 61: e179\u2013e347.","DOI":"10.1016\/j.jacc.2013.01.014"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. <i>J Am Coll Cardiol<\/i> 2014; 64: e139.","DOI":"10.1016\/j.jacc.2014.09.017"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jneid H, Addison D, Bhatt DL, Fonarow GC, Gokak S, Grady KL, et al. 2017 AHA\/ACC clinical performance and quality measures for adults with ST-elevation and non-ST-elevation myocardial infarction: A Report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures. <i>J Am Coll Cardiol<\/i> 2017; 70: 2048\u20132090.","DOI":"10.1016\/j.jacc.2017.06.032"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, et al. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan: 2012 version. <i>J Atheroscler Thromb<\/i> 2013; 20: 517\u2013523.","DOI":"10.5551\/jat.15792"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias. <i>Eur Heart J<\/i> 2016; 37: 2999\u20133058.","DOI":"10.1093\/eurheartj\/ehw272"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2019; 73: 3168\u20133209.","DOI":"10.1016\/j.jacc.2018.11.002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, et al. Alirocumab and cardiovascular outcomes after acute coronary syndrome. <i>N Engl J Med<\/i> 2018; 379: 2097\u20132107.","DOI":"10.1056\/NEJMoa1801174"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. <i>J Am Coll Cardiol<\/i> 2001; 37: 1478\u20131492.","DOI":"10.1016\/S0735-1097(01)01175-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nicholls SJ, Hsu A, Wolski K, Hu B, Bayturan O, Lavoie A, et al. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. <i>J Am Coll Cardiol<\/i> 2010; 55: 2399\u20132407.","DOI":"10.1016\/j.jacc.2010.02.026"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ako J, Hibi K, Kozuma K, Miyauchi K, Morino Y, Shinke T, et al. Effect of alirocumab on coronary atheroma volume in Japanese patients with acute coronary syndromes and hypercholesterolemia not adequately controlled with statins: ODYSSEY J-IVUS rationale and design. <i>J Cardiol<\/i> 2018; 71: 583\u2013589.","DOI":"10.1016\/j.jjcc.2017.11.013"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. <i>Clin Chem<\/i> 1972; 18: 499\u2013502.","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nakajima N, Miyauchi K, Yokoyama T, Ogita M, Miyazaki T, Tamura H, et al. Effect of combination of ezetimibe and a statin on coronary plaque regression in patients with acute coronary syndrome: ZEUS trial (eZEtimibe Ultrasound Study). <i>IJC Metabol Endocr<\/i> 2014; 3: 8\u201313.","DOI":"10.1016\/j.ijcme.2014.03.001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, et al. Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: The multicenter randomized controlled PRECISE-IVUS trial. <i>J Am Coll Cardiol<\/i> 2015; 66: 495\u2013507.","DOI":"10.1016\/j.jacc.2015.05.065"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, et al. Effect of ACAT inhibition on the progression of coronary atherosclerosis. <i>N Engl J Med<\/i> 2006; 354: 1253\u20131263.","DOI":"10.1056\/NEJMoa054699"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. <i>JAMA<\/i> 2004; 291: 1071\u20131080.","DOI":"10.1001\/jama.291.9.1071"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, et al. Effect of two intensive statin regimens on progression of coronary disease. <i>N Engl J Med<\/i> 2011; 365: 2078\u20132087.","DOI":"10.1056\/NEJMoa1110874"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nicholls SJ, Puri R, Anderson T, Ballantyne CM, Cho L, Kastelein JJ, et al. Effect of evolocumab on progression of coronary disease in statin-treated patients: The GLAGOV randomized clinical trial. <i>JAMA<\/i> 2016; 316: 2373\u20132384.","DOI":"10.1001\/jama.2016.16951"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Jones PH, Bays HE, Chaudhari U, Pordy R, Lorenzato C, Miller K, et al. Safety of alirocumab (a PCSK9 monoclonal antibody) from 14 randomized trials. <i>Am J Cardiol<\/i> 2016; 118: 1805\u20131811.","DOI":"10.1016\/j.amjcard.2016.08.072"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/10\/83_CJ-19-0412\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T01:20:52Z","timestamp":1610846452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/10\/83_CJ-19-0412\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-0412","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,25]]}}}